OPPM
ASMB icon

Opus Point Partners Management’s Assembly Biosciences ASMB Stock Holding History

Opus Point Partners Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,250
Closed -$143K – 59
2015
Q3 		$143K Sell
1,250
-4,167
-77% -$733K 0.08% 54
2015
Q2 		$1.25M Hold
5,417
– – 0.99% 30
2015
Q1 		$861K Buy
+5,417
New +$733K 0.72% 36

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Opus Point Partners Management's ASMB Position: Q4 2015 in Review

Opus Point Partners Management sold out of Assembly Biosciences (ASMB) in Q4 2015, closing a stake of 1,250 shares — an estimated $143K sold.

Opus Point Partners Management first reported a position in ASMB in Q1 2015 and held it in 3 quarters. The position peaked at $1.25M in Q2 2015. 48 funds tracked by Wall St. Rank hold ASMB as of Q4 2015.

  • Opus Point Partners Management reported no remaining Assembly Biosciences position as of Q4 2015 after selling out during the quarter.
  • Opus Point Partners Management sold 1,250 Assembly Biosciences shares in Q4 2015, an estimated $143K.
  • Opus Point Partners Management first reported a position in Assembly Biosciences in Q1 2015 and held it in 3 quarters.
  • Opus Point Partners Management's Assembly Biosciences position peaked at $1.25M in Q2 2015.
  • 48 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2015.

Based on Opus Point Partners Management's 13F filing for Q4 2015, filed 16 Feb 2016.